Patents by Inventor Christopher Ganser

Christopher Ganser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment
    Patent number: 11045449
    Abstract: The present invention relates to 3-(5-fluoroindolyl)-4-arylmaleimide compounds and pharmaceutical compositions containing them. The compounds of the present invention are protein kinases (GSK-3beta, VEGFR-2 and FLT-3) with antineoplastic activity. They can therefore be used for the treatment or prevention of tumors, in particular solid tumors.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: June 29, 2021
    Assignees: JOHANNES GUTENBERG-UNIVERSITÄT MAINZ, UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ
    Inventors: Markus Möhler, Annett Maderer, Gerd Dannhardt, Christopher Ganser, Eva Lauermann, René Mönnikes
  • 3-(5-Fluoroindolyl)-4-arylmaleimide Compounds and their Use in Tumor Treatment
    Publication number: 20200253930
    Abstract: The present invention relates to 3-(5-fluoroindolyl)-4-arylmaleimide compounds and pharmaceutical compositions containing them. The compounds of the present invention are protein kinases (GSK-3beta, VEGFR-2 and FLT-3) with antineoplastic activity. They can therefore be used for the treatment or prevention of tumors, in particular solid tumors.
    Type: Application
    Filed: December 28, 2016
    Publication date: August 13, 2020
    Inventors: Markus Möhler, Annett Maderer, Gerd Dannhardt, Christopher Ganser, Eva Lauermann, René Mönnikes
  • Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
    Patent number: 8957103
    Abstract: The present invention relates to 3-(Indolyl)- and 3-(azaindolyl)-4-phenylmaleimide compounds of formula (I) wherein R1, R2 and R3 are as defined in the description, and the physiologically acceptable salts, solvates and solvates of the salts of the compounds of formula (I). The compounds of formula (I) are suitable for treating tumors.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: February 17, 2015
    Assignee: Johannes Gutenberg—Universitat Mainz
    Inventors: Gerd Dannhardt, Stanislav Plutizki, Christopher Ganser, Eva Lauermann
  • CONJUGATED 3-(INDOLYL)- AND 3-(AZAINDOLYL)-4-ARYLMALEIMIDE COMPOUNDS AND THEIR USE IN TUMOR TREATMENT
    Publication number: 20130345281
    Abstract: The present invention relates to 3-(Indolyl)- and 3-(azaindolyl)-4-phenylmaleimide compounds of formula (I) wherein R1, R2 and R3 are as defined in the description, and the physiologically acceptable salts, solvates and solvates of the salts of the compounds of formula (I). The compounds of formula (I) are suitable for treating tumors.
    Type: Application
    Filed: December 15, 2011
    Publication date: December 26, 2013
    Applicant: JOHANNES GUTENBERG-UNIVERSITAT MAINZ
    Inventors: Gerd Dannhardt, Stanislav Plutizki, Christopher Ganser, Eva Lauermann